Skip to content

Study for the nosocomial infection rate of therapy for malignant biliary obstruction by biliary stent loaded with radioactive 125I seeds versus conventional biliary stent

The nosocomial infection rate of therapy for malignant biliary obstruction by biliary stent loaded

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024102
Enrollment
Unknown
Registered
2019-06-25
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant biliary obstruction

Interventions

Group 1:biliary stent loaded with radioactive 125I seeds (radioactive biliary stent, RBS)
Group 2:Conventional biliary stent loading

Sponsors

Qinhuangdao Municipal 1st Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: Through clinical symptoms, signs and related auxiliary examinations, patients diagnosed as MBO are clearly. And obstruction site locates in the middle and low level of the bile duct (Bismuth-Corlette I and lower biliary obstruction). They have not undergone any surgical, interventional treatment and ERCP examination. There was no clear biliary infection and other infections before operation (no fever, white blood cells (WBC) counts are not exceeding 9x10^9 per unit, the percentage of neutrophils are not exceeding 70%). Antibiotics were not used in any form before surgery.

Exclusion criteria

Exclusion criteria: After surgery, there are typical fever symptoms within 1 week, and the body temperature rises by 1 degree C from the basic body temperature, and fever continues to occur for 3 days. The blood analysis within 1 week after surgery shows that the WBC counts exceed 10x10^9 per unit, and the percentage of neutrophils exceed 75%. Blood culture has bacteria. And the bilirubin doesnt decrease but increased.

Design outcomes

Primary

MeasureTime frame
The nosocomial infection rate;

Secondary

MeasureTime frame
Pathogenic culture and identification;

Countries

China

Contacts

Public ContactHongtao Niu

Qinhuangdao Municipal 1st Hospital

niuht2004@126.com+86 18703352928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026